Teva Pharmaceutical Industries Limited

ISIN IL0006290147 Symbol TEVA Industry Drug Manufacturers-Specialty & Generic Sector Healthcare
Teva Pharmaceutical Industries Price
3,436.0ILS 0.78%
1y Low: 2,879.0
1y High: 4,623.0
1y Low: 2,879.0
1y High: 4,623.0
tevapharm.com
Market Cap
11.0 B USD
Dividend Yield
Performance 1y
15.26 %
PER
921.4

Teva Pharmaceutical Industries Stock Chart

Teva Pharmaceutical Industries Dividend Chart

Teva Pharmaceutical Industries Dividend Calendar

Year # Div. Div. Paid Div. Yield Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2021 0 0 ILS 0.0 %
2020 0 0 ILS 0.0 %
2019 0 0 ILS 0.0 %
2018 0 0 ILS 0.0 %
2017 4 85.00 ILS 1.3 %
2016 4 136.0 ILS 1.0 %
2015 4 426.8 ILS 1.7 %
2014 4 484.0 ILS 2.2 %
2013 4 460.0 ILS 3.5 %
2012 4 400.0 ILS 3.2 %
2011 4 320.0 ILS 2.3 %
2010 4 273.7 ILS 1.7 %
2009 4 240.0 ILS 1.3 %
2008 4 180.0 ILS 1.3 %
2007 4 160.0 ILS 1.1 %
2006 4 136.0 ILS 1.2 %
2005 4 120.0 ILS 0.7 %
2004 4 90.00 ILS 0.9 %
2003 4 66.00 ILS 0.7 %
2002 2 21.50 ILS 0.3 %

Teva Pharmaceutical Industries Performance

1 Week
0.56 %
1 Month
0.085 %
6 Months
5.73 %
Year to Date
12.76 %
1 Year
15.26 %
5 Years
82.22 %

Teva Pharmaceutical Industries Revenue, EBIT, and Income

Teva Pharmaceutical Industries Margins

Teva Pharmaceutical Industries Shares Outstanding

Useful Links

Search Twitter: $TEVA, #TEVA

Teva Pharmaceutical Industries Company Info

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, the company provides specialty medicines for use in central nervous system and respiratory indications. Further, its products in the central nervous system and pain area comprise Copaxone for the treatment of relapsing forms of MS; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. Additionally, the company's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Braltus, Cinqair/Cinqaero, and AirDuo RespiClick/ArmonAir RespiClick/AirDuo Digihaler for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. It has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.

Teva Pharmaceutical Industries Headquarter

5 Basel Street, 4951033 Petah Tikva, Israel

Teva Pharmaceutical Industries Price to Earnings Ratio (PE Ratio): 921.4

The current Price to Earnings Ratio of Teva Pharmaceutical Industries is 921.4.
The PE Ratio is calcluated by dividing the current Teva Pharmaceutical Industries share price (3,436.0 ILS) by the earnings per share (0.0).

Teva Pharmaceutical Industries Market Cap: 11.0 B USD

The current market cap of Teva Pharmaceutical Industries is 11.0 B USD.

Teva Pharmaceutical Industries Stock Price: 3,436.0 ILS

The current stock price of Teva Pharmaceutical Industries is 3,436.0 ILS (1,028.3 USD).

Teva Pharmaceutical Industries ISIN: IL0006290147

The ISIN (International Securities Identification Number) of Teva Pharmaceutical Industries is IL0006290147.

Teva Pharmaceutical Industries Ticker Symbol: TEVA

The ticker symbol of Teva Pharmaceutical Industries is TEVA.

Teva Pharmaceutical Industries Address

The address of the Teva Pharmaceutical Industries HQ is 5 Basel Street, 4951033 Petah Tikva, Israel.